Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
4
×
san diego blog main
san diego top stories
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
celgene
deals
drug prices
fda
pfizer
sanofi
2019
abiraterone
ac immune
acorda therapeutics
activism
acute hepatic porphyria
What
drug
4
×
gene
4
×
bio
roundup
fda
prices
therapy
advanced
alnylam
alnylam’s
alzheimer’s
approval
approves
aren’t
bff
cells
companies
conference
deals
developers
devoted
different
disease
drugs
easl
ema
employ
europe
fail
follows
form
harmful
help
hits
imminent
increases
interference
kicked
latest
liver
Language
Current search:
drug
×
" new york top stories "
×
gene
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More